Hypha Labs, Inc.
FUNI
$0.029
-$0.001-3.33%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 159.61% | -18.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 159.61% | -18.06% | |||
| Operating Income | -159.61% | 18.06% | |||
| Income Before Tax | -180.37% | 34.51% | |||
| Income Tax Expenses | -- | 48.02% | |||
| Earnings from Continuing Operations | -187.47% | 34.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -187.47% | 34.08% | |||
| EBIT | -159.61% | 18.06% | |||
| EBITDA | -159.79% | 18.19% | |||
| EPS Basic | -176.92% | 40.91% | |||
| Normalized Basic EPS | -144.44% | 27.03% | |||
| EPS Diluted | -176.92% | 61.00% | |||
| Normalized Diluted EPS | -144.44% | 27.03% | |||
| Average Basic Shares Outstanding | 5.09% | 10.07% | |||
| Average Diluted Shares Outstanding | 5.09% | 10.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||